EGLN1 and diabetic kidney disease: Moreover, apoptosis, another classical marker of ROS damage in diabetic nephropathy (Allen et al., 2003), was reduced not only in DMOG-treated mIMCD3 cells exposed to high glucose concentrations in hypoxia but also in DMOG-treated Leprdb/db mice and diabetic Egln1+/- mice.